OTCMKTS:CDMGF - Icade Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$92.93
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Icade Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CDMGF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CDMGF

Average Price Target: $0.00
▼ -100.00% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Icade in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $92.93.

Hold

The current consensus among 5 polled investment analysts is to hold stock in Icade.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/23/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
9/21/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings
12/20/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
5/19/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
6/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/2/2021BarclaysReiterated RatingUnderweight
3/2/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight
1/22/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
1/19/2021BarclaysReiterated RatingUnderweight
11/9/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral
10/23/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
10/20/2020Bank of AmericaUpgradeNeutral ➝ Buy
9/3/2020Morgan StanleyReiterated RatingEqual Weight
7/22/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
6/4/2020BarclaysReiterated RatingUnderweight
5/11/2020Morgan StanleyReiterated RatingEqual Weight
4/30/2020JPMorgan Chase & Co.Reiterated RatingNeutral
4/3/2020The Goldman Sachs GroupReiterated RatingSell
(Data available from 6/18/2016 forward)
Icade logo
As an investor and a developer, Icade is an integrated real estate player that designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is closely involved with stakeholders and users in the citiesÂlocal authorities and communities, companies and employees, institutions and associations As an office and healthcare property investor (portfolio value of Â11.6bn as of 06/30/2020 on a proportionate consolidation basis) and as a property developer (2019 economic revenues of nearly Â1bn), Icade has been able to reinvent the real estate business and foster the emergence of tomorrow's greener, smarter and more responsible cities. Icade is a significant player in the Greater Paris area and major French cities. Icade is listed on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC). Its leading shareholder is the Caisse des dépôts Group.
Read More

Today's Range

Now: $92.93
Low: $92.93
High: $92.93

50 Day Range

MA: $82.76
Low: $72.64
High: $92.93

52 Week Range

Now: $92.93
Low: $50.60
High: $92.93

Volume

N/A

Average Volume

300 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Icade?

The following sell-side analysts have issued research reports on Icade in the last year: Bank of America Co., Barclays PLC, Deutsche Bank Aktiengesellschaft, Morgan Stanley, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for CDMGF.

What is the current price target for Icade?

0 Wall Street analysts have set twelve-month price targets for Icade in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Icade in the next year.
View the latest price targets for CDMGF.

What is the current consensus analyst rating for Icade?

Icade currently has 1 sell rating, 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CDMGF, but not buy more shares or sell existing shares.
View the latest ratings for CDMGF.

What other companies compete with Icade?

How do I contact Icade's investor relations team?

The company's listed phone number is 33 1 41 57 70 00. The official website for Icade is www.icade.fr.